data_1ka6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ka6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.776 0.322 . . . . 4.3099999999999996 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.33 74.96 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 2.6899999999999999 110.743 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.06 70.1 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 1.54 111.065 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.86 134.34 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.916 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.11 -41.12 43.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.02 111.207 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -83.88 49.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 1.0600000000000001 111.347 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -108.16 91.62 3.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 2.04 110.775 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.701 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 76.1 m-70 -65.73 -22.02 66.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.40999999999999998 111.043 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.45 -136.75 13.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.735 . . . . 0.34000000000000002 112.606 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -84.41 95.55 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.798 0.332 . . . . 2.5499999999999998 110.953 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 32' ' ' ARG . 12.1 pt -135.44 136.44 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 1.04 111.242 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.58 154.48 28.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.97999999999999998 110.907 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' HD3' ' HG1' ' B' ' 279' ' ' THR . 12.3 ttm180 -53.47 -26.29 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 2.5600000000000001 110.715 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.8 -43.12 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.69999999999999996 110.87 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -59.81 -47.58 85.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 1.0700000000000001 110.833 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.99 86.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.10000000000000001 112.131 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.819 ' HB3' HD13 ' B' ' 278' ' ' LEU . 29.4 mt-10 -71.59 -40.98 69.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.14999999999999999 110.816 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -72.04 -31.76 66.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 1.3600000000000001 110.797 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.38 -55.03 31.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 1.0600000000000001 110.665 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.588 ' HG ' HD21 ' A' ' 30' ' ' LEU . 60.8 mt -59.87 -42.28 93.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.02 110.667 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.3 mt -55.48 -43.69 75.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 1.05 111.156 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.96 95.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 1.02 111.494 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -51.77 67.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.41 . . . . 1.02 111.276 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.25 32.65 65.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.747 . . . . 0.14000000000000001 112.69 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 mt -132.8 119.28 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.98999999999999999 110.849 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.95 153.95 20.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.62 111.1 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 99' ' ' GLN . . . 81.67 -16.0 22.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.013 -0.613 . . . . 0.080000000000000002 112.78 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.748 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 58.2 m -55.18 150.24 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.188 -0.301 . . . . 0.80000000000000004 110.188 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.583 ' HB2' HD12 ' A' ' 43' ' ' LEU . 54.5 p90 -154.1 162.56 41.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.141 0.496 . . . . 0.90000000000000002 112.197 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.588 HD21 ' HG ' ' A' ' 20' ' ' LEU . 1.4 pp -158.01 177.99 10.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.491 -0.777 . . . . 1.03 110.584 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.475 HD11 HD11 ' A' ' 43' ' ' LEU . 6.8 mp -123.22 144.57 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.093 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -143.71 149.96 37.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 2.52 110.763 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.68 106.83 18.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.67000000000000004 110.387 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.8 t -48.83 114.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.82999999999999996 111.272 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.68 -57.79 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 1.9399999999999999 111.057 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -30.68 68.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 1.04 110.97 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.696 HG11 HG22 ' A' ' 40' ' ' VAL . 2.8 t -121.22 83.34 39.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 1.1299999999999999 110.996 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.16 130.25 29.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.253 . . . . 0.71999999999999997 112.441 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -14.4 45.39 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.807 -0.711 . . . . 0.32000000000000001 112.597 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.696 HG22 HG11 ' A' ' 37' ' ' VAL . 47.2 t -106.97 143.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 1.04 111.19 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -104.03 152.04 22.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.95999999999999996 110.799 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' HB3' HG23 ' A' ' 53' ' ' THR . 67.6 m -125.38 124.59 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 1.22 111.053 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 29' ' ' TYR . 14.4 tp -94.3 109.63 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.037 -0.529 . . . . 1.03 110.542 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 10.2 m -86.23 145.87 26.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 1.1799999999999999 111.161 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.4 t -134.81 139.72 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.02 110.779 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.29 128.38 44.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.09 -0.505 . . . . 1.04 111.036 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -164.34 115.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.95999999999999996 110.835 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.1 m170 58.25 38.14 26.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.46000000000000002 110.946 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.17 28.7 71.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.881 -0.676 . . . . 0.16 112.696 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' HB3' HD12 ' B' ' 280' ' ' ILE . 14.4 m-85 -122.22 165.16 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.81999999999999995 111.092 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.721 HG12 ' HA ' ' A' ' 17' ' ' GLU . 4.8 mp -130.61 97.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 1.04 111.079 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CZ ' HG21 ' A' ' 95' ' ' VAL . 57.5 m-85 -83.43 126.53 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.83999999999999997 110.517 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 42' ' ' CYS . 1.4 m -111.51 134.43 53.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 1.03 111.434 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.445 ' HD1' ' HB3' ' B' ' 282' ' ' ALA . 6.3 m-85 -120.07 145.91 46.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.96 -0.563 . . . . 0.89000000000000001 110.268 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 7.4 mtm-85 -83.62 112.31 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 2.1899999999999999 111.463 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -118.35 114.57 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 1.0600000000000001 110.613 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.42 159.96 40.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.93999999999999995 111.169 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -97.1 121.61 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.94999999999999996 110.799 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -70.75 -178.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 1.0600000000000001 111.173 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -74.14 -8.81 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 2.1000000000000001 111.086 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -93.93 5.99 49.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.362 -0.381 . . . . 1.4399999999999999 111.189 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.27 34.95 69.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.46000000000000002 112.506 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.4 42.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.94999999999999996 110.928 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.74 121.67 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.23999999999999999 110.961 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.78 146.21 49.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.81999999999999995 110.906 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.5 136.09 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 1.0800000000000001 111.195 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 3.2 tt0 -106.96 109.75 21.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 1.1699999999999999 110.772 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -109.32 -157.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 1.05 111.102 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 154.74 93.91 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.347 -0.388 . . . . 1.0700000000000001 111.058 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.01 164.06 2.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.534 2.156 . . . . 0.40999999999999998 112.3 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.72 2.86 88.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.40000000000000002 112.534 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.716 HG12 ' HA3' ' A' ' 93' ' ' GLY . 96.0 t -129.18 117.49 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 1.0800000000000001 111.02 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -68.5 144.04 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.71999999999999997 110.893 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 112.88 23.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 2.2400000000000002 110.836 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -74.56 146.05 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 3.5699999999999998 110.82 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -105.2 120.03 40.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.94999999999999996 110.918 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.66 155.01 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.28999999999999998 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -82.64 -34.47 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 3.29 110.871 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -126.44 147.78 49.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.3999999999999999 110.73 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 81' ' ' LYS . 8.0 tp -64.65 -35.06 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 1.02 110.995 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -64.6 -29.73 70.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.936 0.398 . . . . 1.49 110.474 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.54 -27.64 65.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.987 -0.551 . . . . 0.90000000000000002 110.677 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -65.37 -52.59 52.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.696 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 67.8 mt -60.17 -36.26 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 1.04 111.171 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.1 p -66.81 -34.25 77.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 1.27 111.315 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.89 60.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 1.04 111.458 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -84.84 7.68 20.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.23000000000000001 110.994 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 91.5 mt-30 -92.69 19.6 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.40000000000000002 110.827 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.48 154.52 48.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.054 -0.521 . . . . 1.76 110.928 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.87 168.47 10.36 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.501 2.134 . . . . 0.16 112.317 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 57.74 73.71 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.80000000000000004 110.882 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -144.33 11.11 1.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.51000000000000001 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.716 ' HA3' HG12 ' A' ' 72' ' ' VAL . . . 69.61 49.11 39.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.795 -0.717 . . . . 0.17000000000000001 112.57 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 97' ' ' PRO . 3.0 pt -146.06 168.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.696 0.284 . . . . 1.0600000000000001 110.931 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 96' ' ' ILE . 12.7 p -67.83 -36.31 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 1.02 111.243 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' N ' HG12 ' A' ' 95' ' ' VAL . 8.0 tt -165.64 135.48 2.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.975 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 96' ' ' ILE . 21.6 Cg_exo -65.73 139.49 57.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.527 2.152 . . . . 0.089999999999999997 112.084 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.572 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 17.9 mt -49.55 147.16 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 1.05 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 36.3 mt-30 -152.61 -22.16 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.116 0.413 . . . . 0.28999999999999998 112.116 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.748 ' O ' ' HA ' ' A' ' 28' ' ' SER . 13.2 m-85 -135.32 84.17 36.07 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.485 0.55 . . . . 0.94999999999999996 112.485 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.25 120.28 7.73 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.878 2.385 . . . . 0.12 112.314 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.6 t -86.11 79.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.725 -0.67 . . . . 1.01 110.441 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.83 147.88 14.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 1.5900000000000001 111.295 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.701 ' HG3' ' HA ' ' A' ' 8' ' ' HIS . 1.2 tttt -93.81 90.58 6.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.8700000000000001 110.805 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.96 52.85 8.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.113 -0.494 . . . . 3.5099999999999998 110.977 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.55 10.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 3.5299999999999998 110.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.224 -0.893 . . . . 4.9400000000000004 110.913 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.797 0.332 . . . . 9.4800000000000004 111.235 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.02 -74.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 7.0300000000000002 110.885 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.26 101.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 2.2400000000000002 110.852 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.819 HD13 ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -90.85 -7.63 51.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 1.02 110.77 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' THR . . . . . 0.52 ' HG1' ' HD3' ' A' ' 13' ' ' ARG . 1.8 t -102.96 143.14 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 111.194 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 50' ' ' TYR . 7.8 mt -128.52 -23.23 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 1.1000000000000001 111.095 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' PTR . . . . . 0.48 ' HE2' ' HD3' ' A' ' 13' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . 0.445 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . . . -171.87 135.1 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 1.0600000000000001 111.073 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 1.8500000000000001 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.776 0.322 . . . . 3.7999999999999998 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.33 74.96 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 2.6899999999999999 110.743 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.06 70.1 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.93999999999999995 111.065 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 31' ' ' LEU . 46.4 t -123.86 134.34 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.33000000000000002 110.916 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.11 -41.12 43.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.29999999999999999 111.207 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 102' ' ' VAL . 5.4 m -83.88 49.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.32000000000000001 111.347 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -108.16 91.62 3.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 1.1699999999999999 110.775 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.711 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 76.1 m-70 -65.73 -22.02 66.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.34999999999999998 111.043 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.45 -136.75 13.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.735 . . . . 0.34000000000000002 112.606 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -84.41 95.55 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 110.953 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 32' ' ' ARG . 12.1 pt -135.44 136.44 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.20000000000000001 111.242 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.58 154.48 28.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.35999999999999999 110.907 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' HD3' ' HE2' ' B' ' 281' ' ' PTR . 12.3 ttm180 -53.47 -26.29 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 1.8300000000000001 110.715 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.8 -43.12 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.69999999999999996 110.87 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -59.81 -47.58 85.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.14000000000000001 110.833 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.99 86.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.10000000000000001 112.131 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 51' ' ' ILE . 29.4 mt-10 -71.59 -40.98 69.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.14999999999999999 110.816 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -72.04 -31.76 66.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.76000000000000001 110.797 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.38 -55.03 31.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.14999999999999999 110.665 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.874 ' HB3' HD13 ' A' ' 46' ' ' LEU . 60.8 mt -59.87 -42.28 93.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.11 110.667 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.662 HD11 HD22 ' B' ' 278' ' ' LEU . 32.3 mt -55.48 -43.69 75.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.14999999999999999 111.156 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.96 95.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.13 111.494 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -51.77 67.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.41 . . . . 0.17999999999999999 111.276 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.25 32.65 65.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.747 . . . . 0.14000000000000001 112.69 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 46' ' ' LEU . 10.5 mt -132.8 119.28 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.20999999999999999 110.849 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.95 153.95 20.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.62 111.1 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 99' ' ' GLN . . . 81.67 -16.0 22.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.013 -0.613 . . . . 0.070000000000000007 112.78 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 58.2 m -55.18 150.24 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.188 -0.301 . . . . 0.10000000000000001 110.188 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 98' ' ' LEU . 54.5 p90 -154.1 162.56 41.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.141 0.496 . . . . 0.12 112.197 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.4 pp -158.01 177.99 10.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.491 -0.777 . . . . 0.070000000000000007 110.584 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 4' ' ' VAL . 6.8 mp -123.22 144.57 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.16 111.093 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -143.71 149.96 37.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 1.8799999999999999 110.763 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.68 106.83 18.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.67000000000000004 110.387 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.8 t -48.83 114.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.272 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.68 -57.79 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 1.9399999999999999 111.057 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -30.68 68.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.5 110.97 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.22 83.34 39.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.31 110.996 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.16 130.25 29.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.253 . . . . 0.51000000000000001 112.441 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -14.4 45.39 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.807 -0.711 . . . . 0.32000000000000001 112.597 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.97 143.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.17000000000000001 111.19 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -104.03 152.04 22.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.20000000000000001 110.799 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.784 ' HB3' HG23 ' A' ' 53' ' ' THR . 67.6 m -125.38 124.59 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.17999999999999999 111.053 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' HD2' ' A' ' 54' ' ' TYR . 14.4 tp -94.3 109.63 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.037 -0.529 . . . . 0.11 110.542 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.582 ' HB3' HG23 ' A' ' 51' ' ' ILE . 10.2 m -86.23 145.87 26.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.17999999999999999 111.161 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.4 t -134.81 139.72 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.070000000000000007 110.779 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 20' ' ' LEU . 22.1 tp -97.29 128.38 44.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.059999999999999998 111.036 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -164.34 115.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.22 110.835 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.1 m170 58.25 38.14 26.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.34999999999999998 110.946 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.17 28.7 71.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.881 -0.676 . . . . 0.16 112.696 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CG ' HD11 ' B' ' 280' ' ' ILE . 14.4 m-85 -122.22 165.16 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.22 111.092 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 17' ' ' GLU . 4.8 mp -130.61 97.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.080000000000000002 111.079 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.478 ' CD1' HG11 ' A' ' 95' ' ' VAL . 57.5 m-85 -83.43 126.53 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.14999999999999999 110.517 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 42' ' ' CYS . 1.4 m -111.51 134.43 53.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.14999999999999999 111.434 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' HD1' ' HB3' ' B' ' 282' ' ' ALA . 6.3 m-85 -120.07 145.91 46.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.96 -0.563 . . . . 0.31 110.268 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 7.4 mtm-85 -83.62 112.31 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 1.6200000000000001 111.463 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -118.35 114.57 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.14999999999999999 110.613 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.42 159.96 40.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.38 111.169 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -97.1 121.61 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.88 110.799 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -70.75 -178.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.31 111.173 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -74.14 -8.81 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 2.1000000000000001 111.086 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -93.93 5.99 49.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.362 -0.381 . . . . 0.71999999999999997 111.189 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.27 34.95 69.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.46000000000000002 112.506 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.4 42.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.27000000000000002 110.928 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.74 121.67 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.20999999999999999 110.961 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.78 146.21 49.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.23000000000000001 110.906 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.5 136.09 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.19 111.195 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 3.2 tt0 -106.96 109.75 21.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 1.1699999999999999 110.772 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -109.32 -157.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 111.102 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 154.74 93.91 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.347 -0.388 . . . . 0.22 111.058 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.01 164.06 2.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.534 2.156 . . . . 0.39000000000000001 112.3 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.72 2.86 88.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.35999999999999999 112.534 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG11 ' HA3' ' A' ' 93' ' ' GLY . 96.0 t -129.18 117.49 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.31 111.02 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -68.5 144.04 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.59999999999999998 110.893 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 112.88 23.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.836 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -74.56 146.05 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 2.9300000000000002 110.82 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -105.2 120.03 40.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.31 110.918 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.66 155.01 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.23999999999999999 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -82.64 -34.47 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 2.8100000000000001 110.871 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -126.44 147.78 49.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.8500000000000001 110.73 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -64.65 -35.06 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.14999999999999999 110.995 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -29.73 70.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.936 0.398 . . . . 0.90000000000000002 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.54 -27.64 65.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.987 -0.551 . . . . 0.56999999999999995 110.677 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -65.37 -52.59 52.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 0.17000000000000001 110.696 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 67.8 mt -60.17 -36.26 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 0.17000000000000001 111.171 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 10.1 p -66.81 -34.25 77.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.92000000000000004 111.315 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.89 60.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.13 111.458 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -84.84 7.68 20.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.17999999999999999 110.994 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 91.5 mt-30 -92.69 19.6 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.40000000000000002 110.827 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.48 154.52 48.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.054 -0.521 . . . . 1.1699999999999999 110.928 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.87 168.47 10.36 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.501 2.134 . . . . 0.16 112.317 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 57.74 73.71 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.80000000000000004 110.882 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -144.33 11.11 1.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.45000000000000001 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.685 ' HA3' HG11 ' A' ' 72' ' ' VAL . . . 69.61 49.11 39.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.795 -0.717 . . . . 0.14000000000000001 112.57 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 pt -146.06 168.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.696 0.284 . . . . 0.16 110.931 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 96' ' ' ILE . 12.7 p -67.83 -36.31 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.080000000000000002 111.243 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 HG13 ' A' ' 95' ' ' VAL . 8.0 tt -165.64 135.48 2.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.14000000000000001 110.975 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 96' ' ' ILE . 21.6 Cg_exo -65.73 139.49 57.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.527 2.152 . . . . 0.080000000000000002 112.084 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.576 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 17.9 mt -49.55 147.16 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.13 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 36.3 mt-30 -152.61 -22.16 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.116 0.413 . . . . 0.28999999999999998 112.116 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 28' ' ' SER . 13.2 m-85 -135.32 84.17 36.07 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.485 0.55 . . . . 0.28999999999999998 112.485 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.25 120.28 7.73 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.878 2.385 . . . . 0.12 112.314 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 47.6 t -86.11 79.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.725 -0.67 . . . . 0.10000000000000001 110.441 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.83 147.88 14.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 1.5900000000000001 111.295 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.711 ' HG3' ' HA ' ' A' ' 8' ' ' HIS . 1.2 tttt -93.81 90.58 6.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.1899999999999999 110.805 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.96 52.85 8.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.113 -0.494 . . . . 3.04 110.977 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.55 10.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 3.3599999999999999 110.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.224 -0.893 . . . . 4.8200000000000003 110.913 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.797 0.332 . . . . 8.8000000000000007 111.235 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.02 -74.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 6.6600000000000001 110.885 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.26 101.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 1.8300000000000001 110.852 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.85 -7.63 51.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.41999999999999998 110.77 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 279' ' ' THR . . . . . . . . . . . . . 1.8 t -102.96 143.14 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.27000000000000002 111.194 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 50' ' ' TYR . 7.8 mt -128.52 -23.23 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.20999999999999999 111.095 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' PTR . . . . . 0.471 ' HE2' ' HD3' ' A' ' 13' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.514 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . . . -171.87 135.1 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 1.0600000000000001 111.073 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 1.1000000000000001 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtm . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.776 0.322 . . . . 3.7999999999999998 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.33 74.96 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 2.6899999999999999 110.743 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.06 70.1 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.179 -0.464 . . . . 0.93999999999999995 111.065 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 31' ' ' LEU . 46.4 t -123.86 134.34 66.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.33000000000000002 110.916 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.11 -41.12 43.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.29999999999999999 111.207 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 102' ' ' VAL . 5.4 m -83.88 49.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.32000000000000001 111.347 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -108.16 91.62 3.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 1.1699999999999999 110.775 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.711 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 76.1 m-70 -65.73 -22.02 66.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.34999999999999998 111.043 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.45 -136.75 13.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.758 -0.735 . . . . 0.34000000000000002 112.606 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -84.41 95.55 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 110.953 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 32' ' ' ARG . 12.1 pt -135.44 136.44 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.20000000000000001 111.242 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.58 154.48 28.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.35999999999999999 110.907 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.471 ' HD3' ' HE2' ' B' ' 281' ' ' PTR . 12.3 ttm180 -53.47 -26.29 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.587 -0.733 . . . . 1.8300000000000001 110.715 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -70.8 -43.12 69.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.832 -0.622 . . . . 0.69999999999999996 110.87 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -59.81 -47.58 85.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.14000000000000001 110.833 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.99 86.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.10000000000000001 112.131 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 51' ' ' ILE . 29.4 mt-10 -71.59 -40.98 69.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.14999999999999999 110.816 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -72.04 -31.76 66.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.76000000000000001 110.797 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.38 -55.03 31.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.14999999999999999 110.665 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.874 ' HB3' HD13 ' A' ' 46' ' ' LEU . 60.8 mt -59.87 -42.28 93.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.11 110.667 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.662 HD11 HD22 ' B' ' 278' ' ' LEU . 32.3 mt -55.48 -43.69 75.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.14999999999999999 111.156 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.96 95.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.13 111.494 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -51.77 67.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.41 . . . . 0.17999999999999999 111.276 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.25 32.65 65.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.73 -0.747 . . . . 0.14000000000000001 112.69 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 46' ' ' LEU . 10.5 mt -132.8 119.28 20.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.348 . . . . 0.20999999999999999 110.849 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.95 153.95 20.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.62 111.1 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 99' ' ' GLN . . . 81.67 -16.0 22.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.013 -0.613 . . . . 0.070000000000000007 112.78 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 100' ' ' TYR . 58.2 m -55.18 150.24 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.188 -0.301 . . . . 0.10000000000000001 110.188 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 98' ' ' LEU . 54.5 p90 -154.1 162.56 41.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.141 0.496 . . . . 0.12 112.197 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.4 pp -158.01 177.99 10.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.491 -0.777 . . . . 0.070000000000000007 110.584 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 4' ' ' VAL . 6.8 mp -123.22 144.57 49.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.16 111.093 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -143.71 149.96 37.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 1.8799999999999999 110.763 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -88.68 106.83 18.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.67000000000000004 110.387 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.8 t -48.83 114.58 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.272 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.68 -57.79 7.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 1.9399999999999999 111.057 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -30.68 68.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.081 -0.509 . . . . 0.5 110.97 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.22 83.34 39.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.31 110.996 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.16 130.25 29.96 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.253 . . . . 0.51000000000000001 112.441 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -14.4 45.39 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.807 -0.711 . . . . 0.32000000000000001 112.597 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.97 143.33 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.17000000000000001 111.19 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -104.03 152.04 22.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.20000000000000001 110.799 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.784 ' HB3' HG23 ' A' ' 53' ' ' THR . 67.6 m -125.38 124.59 41.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.17999999999999999 111.053 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' HD2' ' A' ' 54' ' ' TYR . 14.4 tp -94.3 109.63 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.037 -0.529 . . . . 0.11 110.542 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.582 ' HB3' HG23 ' A' ' 51' ' ' ILE . 10.2 m -86.23 145.87 26.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.961 -0.563 . . . . 0.17999999999999999 111.161 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.4 t -134.81 139.72 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.070000000000000007 110.779 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 20' ' ' LEU . 22.1 tp -97.29 128.38 44.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.059999999999999998 111.036 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -164.34 115.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.22 110.835 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.1 m170 58.25 38.14 26.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.34999999999999998 110.946 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.17 28.7 71.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.881 -0.676 . . . . 0.16 112.696 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CG ' HD11 ' B' ' 280' ' ' ILE . 14.4 m-85 -122.22 165.16 16.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.867 0.365 . . . . 0.22 111.092 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 17' ' ' GLU . 4.8 mp -130.61 97.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.080000000000000002 111.079 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.478 ' CD1' HG11 ' A' ' 95' ' ' VAL . 57.5 m-85 -83.43 126.53 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.14999999999999999 110.517 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 42' ' ' CYS . 1.4 m -111.51 134.43 53.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.14999999999999999 111.434 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' HD1' ' HB3' ' B' ' 282' ' ' ALA . 6.3 m-85 -120.07 145.91 46.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.96 -0.563 . . . . 0.31 110.268 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 7.4 mtm-85 -83.62 112.31 19.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.952 0.406 . . . . 1.6200000000000001 111.463 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.5 t -118.35 114.57 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.927 -0.579 . . . . 0.14999999999999999 110.613 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.42 159.96 40.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 0.38 111.169 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -97.1 121.61 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.88 110.799 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -70.75 -178.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.31 111.173 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -74.14 -8.81 57.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 2.1000000000000001 111.086 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -93.93 5.99 49.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.362 -0.381 . . . . 0.71999999999999997 111.189 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.27 34.95 69.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.46000000000000002 112.506 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 150.4 42.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.27000000000000002 110.928 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -103.74 121.67 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.20999999999999999 110.961 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.78 146.21 49.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.23000000000000001 110.906 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.5 136.09 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.19 111.195 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 3.2 tt0 -106.96 109.75 21.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 1.1699999999999999 110.772 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -109.32 -157.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 111.102 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.43 154.74 93.91 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.347 -0.388 . . . . 0.22 111.058 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.01 164.06 2.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.534 2.156 . . . . 0.39000000000000001 112.3 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.72 2.86 88.76 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 0.35999999999999999 112.534 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG11 ' HA3' ' A' ' 93' ' ' GLY . 96.0 t -129.18 117.49 43.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.31 111.02 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -68.5 144.04 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.59999999999999998 110.893 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 112.88 23.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.836 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -74.56 146.05 42.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 2.9300000000000002 110.82 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -105.2 120.03 40.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.31 110.918 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -106.66 155.01 20.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.23999999999999999 110.952 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -82.64 -34.47 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.1 -0.5 . . . . 2.8100000000000001 110.871 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -126.44 147.78 49.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.8500000000000001 110.73 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.0 tp -64.65 -35.06 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.298 -0.41 . . . . 0.14999999999999999 110.995 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -29.73 70.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.936 0.398 . . . . 0.90000000000000002 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -69.54 -27.64 65.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.987 -0.551 . . . . 0.56999999999999995 110.677 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -65.37 -52.59 52.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.036 -0.529 . . . . 0.17000000000000001 110.696 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 67.8 mt -60.17 -36.26 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 0.17000000000000001 111.171 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 10.1 p -66.81 -34.25 77.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.92000000000000004 111.315 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.89 60.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.13 111.458 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -84.84 7.68 20.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.17999999999999999 110.994 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 91.5 mt-30 -92.69 19.6 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.907 0.384 . . . . 0.40000000000000002 110.827 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.48 154.52 48.95 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.054 -0.521 . . . . 1.1699999999999999 110.928 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.87 168.47 10.36 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.501 2.134 . . . . 0.16 112.317 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 57.74 73.71 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.80000000000000004 110.882 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -144.33 11.11 1.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.45000000000000001 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.685 ' HA3' HG11 ' A' ' 72' ' ' VAL . . . 69.61 49.11 39.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.795 -0.717 . . . . 0.14000000000000001 112.57 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 pt -146.06 168.58 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.696 0.284 . . . . 0.16 110.931 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 96' ' ' ILE . 12.7 p -67.83 -36.31 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.080000000000000002 111.243 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 HG13 ' A' ' 95' ' ' VAL . 8.0 tt -165.64 135.48 2.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.14000000000000001 110.975 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 96' ' ' ILE . 21.6 Cg_exo -65.73 139.49 57.93 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.527 2.152 . . . . 0.080000000000000002 112.084 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.576 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 17.9 mt -49.55 147.16 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.13 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 36.3 mt-30 -152.61 -22.16 0.16 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.116 0.413 . . . . 0.28999999999999998 112.116 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.756 ' O ' ' HA ' ' A' ' 28' ' ' SER . 13.2 m-85 -135.32 84.17 36.07 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.485 0.55 . . . . 0.28999999999999998 112.485 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.25 120.28 7.73 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.878 2.385 . . . . 0.12 112.314 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 47.6 t -86.11 79.74 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.725 -0.67 . . . . 0.10000000000000001 110.441 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.83 147.88 14.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.957 -0.565 . . . . 1.5900000000000001 111.295 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.711 ' HG3' ' HA ' ' A' ' 8' ' ' HIS . 1.2 tttt -93.81 90.58 6.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 1.1899999999999999 110.805 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 56.96 52.85 8.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.113 -0.494 . . . . 3.04 110.977 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.55 10.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 3.3599999999999999 110.911 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.224 -0.893 . . . . 4.8200000000000003 110.913 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.797 0.332 . . . . 8.8000000000000007 111.235 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.02 -74.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 6.6600000000000001 110.885 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.26 101.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 1.8300000000000001 110.852 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -90.85 -7.63 51.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.41999999999999998 110.77 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' THR . . . . . . . . . . . . . 1.8 t -102.96 143.14 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.27000000000000002 111.194 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' ILE . . . . . 0.41 HD11 ' CG ' ' A' ' 50' ' ' TYR . 7.8 mt -128.52 -23.23 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.20999999999999999 111.095 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' PTR . . . . . 0.471 ' HE2' ' HD3' ' A' ' 13' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.514 ' HB3' ' HD1' ' A' ' 54' ' ' TYR . . . -171.87 135.1 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 1.0600000000000001 111.073 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.561 -0.29 . . . . 1.1000000000000001 . . . . . . . . . . 0 0 . 1 stop_ save_